The global Advanced Endoscopic Technologies Market is poised for robust growth as healthcare providers increasingly adopt minimally invasive diagnostic and therapeutic procedures supported by high-definition imaging, AI-assisted visualization, and advanced endoscopic platforms. According to Future Market Insights (FMI), the market is projected to grow from USD 1.1 billion in 2026 to USD 2.8...

NEWARK, Del., July 11, 2026 — The global Healthcare CSF and Plasma Biomarker Market is poised for sustained expansion as precision medicine, neurological disease diagnostics, and personalized healthcare continue transforming clinical decision-making worldwide. According to Future Market Insights (FMI), the market is projected to grow from USD 3,229.4 million in 2026 to USD 6,655.8 million...

NEWARK, Del., September 18, 2026 — According to Future Market Insights (FMI), the global hormone replacement therapy market is projected to expand from USD 21.3 billion in 2026 to USD 37.8 billion by 2036, registering a 5.9% CAGR during the forecast period. The market was valued at USD 20.1 billion in 2025, creating an incremental opportunity of approximately USD 16.5 billion through...

The global Organoids Market is expected to witness rapid growth as pharmaceutical companies, biotechnology firms, and research institutions increasingly adopt human-relevant three-dimensional (3D) organoid models to accelerate drug discovery, disease modeling, and regenerative medicine research. According to Future Market Insights (FMI), the market is projected to expand from USD 91.8 million...

オルガノイド市場概要 世界のオルガノイド市場は、ヘルスケアおよびライフサイエンス業界が研究および治療開発のために高度な3D生物学的モデルを採用するようになり、顕著な成長を目の当たりにしています。 オルガノイドは、幹細胞から開発された小型の実験室で成長した組織構造であり、実際の人間の器官の構造と機能を密接に複製します。 これらのモデルは、従来の2D細胞培養や特定の動物試験方法に代わるより正確な代替手段を提供することにより、生物医学研究を急速に変革しています。 効率的な創薬システムのニーズの高まり、精密医療の需要の増加、および疾患特異的治療アプローチへの焦点の増加は、市場を前進させる主な要因です。 製薬会社は、オルガノイドを使用して、臨床成功率を改善し、医薬品開発のタイムラインを短縮し、治療に対するヒトの反応をよりよく予測しています。...